Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

T M Kennedy; T Chalder; P McCrone; S Darnley; M Knapp; R H Jones; S Wessely

doi:10.3310/hta10190

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

T M Kennedy, T Chalder, P McCrone, S Darnley, M Knapp, R H Jones, S Wessely

Research output: Contribution to journal › Article › peer-review

75 Citations (Scopus)

Abstract

To determine whether cognitive behavioural therapy (CBT) in addition to antispasmodic treatment offers a cost-effective benefit to primary care patients with irritable bowel syndrome (IBS) and to identify predictors of outcome.

Original language	English
Pages (from-to)	iii-iv, ix-x, 1-67
Journal	Health Technology Assessment
Volume	10
Issue number	19
DOIs	https://doi.org/10.3310/hta10190
Publication status	Published - 2006

Access to Document

10.3310/hta10190

Cite this

@article{cba886a253044cbc9597761bf1437583,

title = "Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial",

abstract = "To determine whether cognitive behavioural therapy (CBT) in addition to antispasmodic treatment offers a cost-effective benefit to primary care patients with irritable bowel syndrome (IBS) and to identify predictors of outcome.",

author = "Kennedy, {T M} and T Chalder and P McCrone and S Darnley and M Knapp and Jones, {R H} and S Wessely",

year = "2006",

doi = "10.3310/hta10190",

language = "English",

volume = "10",

pages = "iii--iv, ix--x, 1--67",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "19",

}

TY - JOUR

T1 - Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care

T2 - randomised controlled trial

AU - Kennedy, T M

AU - Chalder, T

AU - McCrone, P

AU - Darnley, S

AU - Knapp, M

AU - Jones, R H

AU - Wessely, S

PY - 2006

Y1 - 2006

N2 - To determine whether cognitive behavioural therapy (CBT) in addition to antispasmodic treatment offers a cost-effective benefit to primary care patients with irritable bowel syndrome (IBS) and to identify predictors of outcome.

AB - To determine whether cognitive behavioural therapy (CBT) in addition to antispasmodic treatment offers a cost-effective benefit to primary care patients with irritable bowel syndrome (IBS) and to identify predictors of outcome.

U2 - 10.3310/hta10190

DO - 10.3310/hta10190

M3 - Article

C2 - 16729918

SN - 1366-5278

VL - 10

SP - iii-iv, ix-x, 1-67

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 19

ER -

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Abstract

Access to Document

Fingerprint

Cite this